Financière de Tubize S.A.
TUB
Rang in Aktien
#2220
Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a... Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a global biopharmaceutical firm, primarily through its investment in UCB. The company is dedicated to discovering and advancing innovative medicines and solutions focused on neurological and immunological disorders. Its current commercial offerings include Cimzia, an established treatment for a range of inflammatory conditions such as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis. For partial-onset seizures in epilepsy, it provides Briviact, Vimpat, and Keppra, alongside Nayzilam, a nasal spray. Neupro addresses Parkinson's disease and restless legs syndrome. Additionally, the portfolio features Evenity, an injectable therapy for osteoporosis, and Bimzelx, used to manage moderate to severe plaque psoriasis. The company's development pipeline highlights several promising candidates: Staccato, aimed at stereotypical prolonged seizures; Bepranemab for Alzheimer's disease; and UCB0599 for Parkinson's disease. Other therapies under investigation include bimekizumab, which targets psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab, for conditions like myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol, intended for systemic lupus erythematosus.
Aktienkurs
$203.04
Marktkapitalisierung
$9.04B
Veränderung (1 Tag)
-7.47%
Veränderung (1 Jahr)
-25.36%
Land
BE
Handel Financière de Tubize S.A. (TUB)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Financière de Tubize S.A. (TUB)
Anzahl der ausstehenden Aktien zum June 2026: 44.51M
Laut den neuesten Finanzberichten und dem Aktienkurs von Financière de Tubize S.A. beträgt die aktuelle Anzahl der ausstehenden Aktien 44.51M. Am Ende von December 2023 hatte das Unternehmen 44.51M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Financière de Tubize S.A. (TUB) von 2003 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 44.51M | 0.00% |
| 2024 | 44.51M | 0.00% |
| 2023 | 44.51M | 0.00% |
| 2022 | 44.51M | 0.00% |
| 2021 | 44.51M | 0.00% |
| 2020 | 44.51M | -0.11% |
| 2019 | 44.56M | 0.11% |
| 2018 | 44.51M | -0.06% |
| 2017 | 44.54M | 0.05% |
| 2016 | 44.52M | -0.08% |
| 2015 | 44.55M | -0.41% |
| 2014 | 44.74M | 0.29% |
| 2013 | 44.61M | 0.00% |
| 2012 | 44.61M | 0.00% |
| 2011 | 44.61M | 0.00% |
| 2010 | 44.61M | 0.00% |
| 2009 | 44.61M | 0.00% |
| 2008 | 44.61M | 0.00% |
| 2007 | 44.61M | 0.00% |
| 2006 | 44.61M | 0.00% |
| 2005 | 44.61M | -1.95% |
| 2004 | 45.49M | 41.99% |
| 2003 | 32.04M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 253.90M | 470.40% |
US
|
|
| 396.00M | 789.64% |
US
|
|
| 478.91M | 975.90% |
AU
|
|
| 62.19M | 39.70% |
NL
|
|
| - | - |
CH
|
